1. Gastro-Intestinal System | 2. Cardiovascular System | 3. Respiratory System | 4. Central Nervous System | 5. Antimicrobials | 6. Endocrine System | 7. Obstetrics, Gynaecology & Urology | 8. Malignant Disease & Immunosuppression | 9. Nutrition & Blood | 10. Musculoskelatal & Joint Diseases | 11. Opthalmology | 12. Ear, Nose & Oropharynx | 13. Dermatology | 14. Immunology & Vaccines | 15. Anaesthetics | GP Centre Home
Antimicrobials
Please click here for the SaSH Microguide
Please click here for the CCG Antimicrobial Guidelines
| 2 Bacterial Infection | ||
| AMINOGLYCOSIDES | NOTES | |
| AMIKACIN | Injection 500mg in 2ml, paediatric 100mg in 2ml
| RESTRICTED May be prescribed when recommended on Microguide or were susceptibility testing results preclude other choices. MICRO Approval Required for all other indications. Therapeutic Drug Monitoring Required Treatment of serious Gram ve infections resistant to gentamicin . Amikacin – Therapeutic drug monitoring |
| GENTAMICIN | Injection 80mg in 2ml, 20mg in 2ml (paediatric) Intrathecal injetion 5mg in 1ml | Therapeutic Drug Monitoring Required, refer to SaSH guideline Consult with MICRO/CLINICAL PHARMACIST in any of the following : Renal Impairment, Abnormal serum levels, continued therapy (more than 2 doses) and patients not suitable for once daily dosing* (pregnancy, infants<6months, endocarditis, CF patients & burns patients) .
|
| NEOMYCIN | 500mg tablets | RESTRICTED Colorectal surgery prophylaxis only MICRO Approval Required for all other indications. |
| TOBRAMYCIN | 80mg/2ml injection 260mg/6ml injection | RESTRICTED Prescribing by paediatric and respiratory clinicians for CF patients (adults and paediatrics) on the advice of the Royal Bromton only. MICRO Approval Required for all other indications. |
| CARBAPENEMS | NOTES | |
| ERTAPENEM | Injection 1g | RESTRICTED May be prescribed when recommended on Microguide (proven or suspected multi-resistant Gram ve infections) or were susceptibility testing results preclude other choices. MICRO Approval Required for all other indications. |
| IMIPENEM + CILASTIN | Injection IM 500mg, IV 500mg | RESTRICTED May be prescribed when recommended on Microguide (proven or suspected multi-resistant Gram ve infections) or were susceptibility testing results preclude other choices. MICRO Approval Required for all other indications. |
| MEROPENEM | Injection 500mg, 1g | RESTRICTED May be prescribed when recommended on Microguide (proven or suspected multi-resistant Gram ve infections) or were susceptibility testing results preclude other choices. MICRO Approval Required for all other indications. |
| CEPHALOSPORINS – first generation | NOTES | |
| Medicines Q&A – Is there a 10% cross-sensitivity between penicillins and cefalosporins? | Is there a 10% cross-sensitivity between penicillins and cephalosporins? | |
| CEFALEXIN | Capsules 250mg, 500mg Suspension 125mg in 5ml, 250mg in 5ml, 500mg in 5ml | 1st line oral cephalosporin of choice |
| CEPHALOSPORINS – second generation | NOTES | |
| CEFUROXIME | Injection 250mg, 750mg, 1.5g | 1st line IV cephalosporin of choice |
| CEPHALOSPORINS – third generation | NOTES | |
| CEFIXIME | Tablets 200mg | RESTRICTED May be prescribed when recommended on Microguide (gram -ve infection when other agents are unsuitable, stat dose in uncomplicated gonorrhoea (unlicensed – GUM only), MICRO Approval Required for all other indications. British Association for Sexual Health and HIV guidelines UK national guideline for the management of gonorrhoea in adults, 2011 (BASHH) |
| CEFOTAXIME | Injection 250mg, 500mg, 1g | RESTRICTED May be prescribed when recommended on Microguide (bacterial meningitis, severe bacterial pneumonias) or were susceptibility testing results preclude other choices. MICRO Approval Required for all other indications. |
| CEFTAZIDIME | Injection 250mg, 500mg, 1g, 2g | RESTRICTED May be prescribed when recommended on Microguide or were susceptibility testing results preclude other choices. MICRO Approval Required for all other indications. |
| CEFTRIAXONE | Injection 250mg, 1g, 2g | RESTRICTED May be prescribed when recommended on Microguide (bacterial meningitis, biliary sepsis, PID, gonorrhoea, community IV programme) or were susceptibility testing results preclude other choices. MICRO Approval Required for all other indications. UK national guideline for the management of gonorrhoea in adults, 2011 (BASHH) |
| GLYOCOPEPTIDES | NOTES | |
| DALBAVANCIN | Injection 500mg | MICROBIOLOGIST & senior pharmacist approval required RESTRICTED for treatment of the following conditions to facilitate earlier discharge in vulnerable adults for whom an IV long line is not appropriate:
|
| TEICOPLANIN | Injection 200mg, 400mg | RESTRICTED for treatment of the following conditions:
|
| VANCOMYCIN | Capsules 250mg Injection 500mg, 1g | Therapeutic drug monitoring required for IV therapy refer to SaSH microguide CONSULT with MICRO / CLINICAL PHARMACIST in any of the following cases 1) Renal Impairment 2) Abnormal serum levels3)Continued therapy ORAL VANCOMYCIN CDI change of treatment Jan 2017 CONTINUOUS INFUSION I/V VANCOMYCIN [CRITICAL CARE SETTING] |
| LINCONSAMIDES | NOTES | |
| CLINDAMYCIN | Capsules 150mg Suspension 150mg in 5ml Injection 300mg in 2ml | RESERVED For patients allergic to penicillin who fall into any of these 4 groups : 1) Staph. aureus infection of bone or soft tissue 2) Human or animal bites 3) SBE 4) Group B streptococcal prophylaxis in maternity patients 5) Clindamycin is also used in bacterial vaginosis Side-Effects (ie diarrhoea) limit use of this drug |
| MACROLIDES | NOTES | |
| AZITHROMYCIN | Capsules 250mg Suspension 200mg in 5ml | MICRO Approval Required RESTRICTED Use GUM & PAEDS are exempt from MICRO approval for treatment of the following: 1) GUM : Chlamydia & related STIs 2) PAEDIATRICS : URTI & LRTI 3 day course |
| CLARITHROMYCIN | Tablets 250mg, 500mg Suspension 125mg in 5ml, 250mg in 5ml Injection 500mg | Annotations on use of Clarithromycin 1) Preferred macrolide for LRTI (erythromycin is macrolide of choice for URTI) 2) Macrolide of choice for (hospitalised) uncomplicated community acquired pneumonias (combined with either benzylpenicillin, co-amoxiclav or amoxicillin) 3) Also used for atypical mycobacterial infections 4) Also used for Helicobacter pylori eradication 7 day course (combined with omeprazole + metronidazole or amoxicillin) 5) Clarithromycin IV reserved for severe community acquired pneumonia 6) Clarithromycin IV is monitored by a Pharmacy Stop Order to limit the use to approved indications |
| ERYTHROMYCIN STEARATE | Tablets 250mg, 500mg SF Suspension 125mg in5ml, 250mg in 5ml, 500mg in 5ml Injection 1g | Annotations on use of Erythromycin 1) Macrolide of choice for uncomplicated community acquired pneumonias (not requiring hospitalisation) when patient is allergic to penicillin 2) Used in bacterial tonsillitis & pharyngitis in patients allergic to penicillin 3) Used in otitis media & sinusitis (bacterial) if allergic to b-lactams 4) Treatment of Campylobacter enteritis when advised by MICRO 5) Erythromycin IV should be given as an infusion over 30-60 minutes. |
| NITROIMIDAZOLE DERIVATIVES | NOTES | |
| METRONIDAZOLE | Tablets 200mg, 400mg Suspension 200mg in 5ml Suppositories 500mg Injection 500mg in 100ml | Annotations on use of Metronidazole 1) General use anaerobic infections 2) Also used for treatment of necrotising fasciitis, intra-abdominal/biliary sepsis & bacterial vaginosis 3) Use for UNCOMPLICATED Clostridium difficile infection Choice of treatment varies upon severity, use algorithms (I&II) below I Clostridium difficile Treatment Algorithm II Clostridium difficile Bristol Stool Chart 4) Optional agent as part of triple therapy against Helicobacter pylori (omeprazole + clarithromycin + either metronidazole or amoxicillin) 7 day course |
| PENICILLINS – Antipseudomonal with beta lactamase inhibitor | NOTES | |
| TAZOCIN [Piperacillin + Tazobactam] | Injection 2.25g, 4.5g | RESTRICTED May be prescribed when recommended on Microguide or were susceptibility testing results preclude other choices. MICRO Approval Required for all other indications. (CONTAINS PENICILLIN) |
| PENICILLINS – Beta-lactamase sensitive | NOTES | |
| Medicines Q&A – What is the clinical significance of the interaction between methotrexate and penicillins? |
| |
| BENZYLPENICILLIN | Injection 600mg, 1.2g | UKMi How do you treat syphilis with parenteral benzylpenicillins |
| PENICILLIN V (phenoxymethypenicillin) | Tablets 125mg, 250mg Syrup 125mg/5ml, 250mg/5ml | |
| PENICILLINS – broad-spectrum | NOTES | |
| AMOXICILLIN | Capsules 250mg, 500mg Syrup 125mg/5ml, 250mg/5ml, 125mg in 1.25ml (restricted to paediatrics/neonatal) Injection 250mg, 500mg, 1g Sachets (SF) 3g | |
| PENICILLINS – broad-spectrum with beta-lactamase inhibitor | NOTES | |
| CO-AMOXICLAV [Amoxicillin/Clavulanic acid] | Tablets 375mg, 625mg Suspension 125/31mg in 5ml SF, 250/62mg in 5ml SF, 400/75mg in 5ml (Paeds only) Injection 600mg, 1.2g | |
| PENICILLINS – mecillinam-type | NOTES | |
| PIVMECILLINAM | Tablets 200mg | MICRO Approval Required (CONTAINS PENICILLIN) RESTRICTED |
| PENICILLINS – penicillinase-resistant | NOTES | |
| FLUCLOXACILLIN | Capsules 250mg, 500mg Syrup 125mg/5ml, 250mg/5ml Injection 500mg, 1g | |
TEMOCILLIN | Injection 1g | ** New Agent Added for Empirical Treatments ** see |
| POLYMYXINS | NOTES | |
| COLISTIMETHATE SODIUM | 500,000 units Vial, 1,000,000 units Vial | RESTRICTED MICROBIOLOGY CONSULTANT approval Required. |
| COLOMYCIN injection 1 million units, 2 million units, suitable for nebulisation | RESTRICTED May be prescribed when recommended on Microguide (paediatrics, serious gram -ve infections and Pseudomonas. Also inhaled via nebulised route in CF) or were susceptibility testing results preclude other choices. MICRO Approval Required for all other indications. | |
| QUINOLONES | NOTES | |
| CIPROFLOXACIN | Tablets 100mg, 250mg, 500mg Suspension 250mg/5ml Infusion 100mg/50ml, 200mg/100ml | Microbiology Policy on Ciprofloxacin Notes on use of Oral Ciprofloxacin 1) Ciprofloxacin should NOT be used for empirical treatment of lower UTI 2) Ciprofloxacin may be used in conjunction with gentamicin for patients allergic to b-lactams to treat the following conditions : UTI, acute prostatitis, gram ve sepsis & neutropenic fever 3) For treatment of Salmonella enteritis, Campylobacter enteritis, bacillary dysentery (Shigella) on MICRO advice |
| LEVOFLOXACIN | Tablets 250mg, 500mg Infusion 500mg/100ml | RESERVED for treatment of community acquired pneumonias in patients allergic to b-lactams |
| MOXIFLOXACIN | Tablets 400mg | RESTRICTED USE MICRO approval or RESPIRATORY CONSULTANT use only. |
| NORFLOXACIN | Tablets 400mg | Reserved for propyhlaxis of spontaneous bacterial peritonitis |
| OFLOXACIN | Tablets 200mg, 400mg | Reserved for treatment of PID (in conjunction with metronidazole) |
| SULPHONAMIDES | NOTES | |
| CO-TRIMOXAZOLE | Tablets 480mg, 960mg Suspension 240mg/5ml, 480mg/5ml Injection 96mg/ml | CO-TRIMOXAZOLE contains a mixture of trimethoprim 1 part to sulfamethoxazole 5 parts RESERVED for treatment of: 1. bacillary dysentery 2. PCP 3. disease due to Stenotrophomonas maltophilia, e.g. ventilator-associated pneumonia . UKMi How to administer intravnous co-trimoxazole in fluid restricted patients |
| SULFADIAZINE | Tablets 500mg 250mg / ml Injection (4ml vial) | Used for toxoplasmosis |
| TETRACYCLINES | NOTES | |
| DEMECLOCYCLINE | Capsules 150mg | Used for treatment of inappropriate secretion of antidiuretic syndrome |
| DOXYCYCLINE | Capsules 50mg, 100mg Tablets soluble 100mg | 1) Doxycycline also used in genital Chlamydia infection 2) Doxycycline also recommended for treatment of suspected PID (in conjunction with metronidazole) 3) Doxycycline also used for treatment of mild skin/soft tissue infections due to MRSA . UK national guideline for the management of Pelvic Inflammatory Disease in adults, 2011 (BASHH) |
| MINOCYCLINE | Tablets 50mg, 100mg SR Capsules 100mg | Minocycline also used for treatment of mild skin/soft tissue infections due to MRSA. APC traffic light status: AMBER Ance APC traffic light status: BLACK Minocycline is non-formulary for acne treatment. APC Policy Statement: Minocycline for acne APC policy statement – Minocycline no-acne indications – June 2019 |
| OXYTETRACYCLINE | Tablets 250mg | |
| TETRACYCLINE | 500 mg Intravenous Injection | |
| TIGECYCLINE | Injection 50mg | RESTRICTED MICROBIOLOGY CONSULTANT Approval Only 1) Treatment of skin & soft tissue infections (excluding diabetic foot ulcers) 2) Treatment of complicated intra-abdominal infections 3) Unlicensed use for community acquired pneumonia & hospital acquired pneumonia 4) Treatment of multi-drug resistant infections |
| ANIBACTERIALS – Other | NOTES | |
| CHLORAMPHENICOL | Capsules 250mg Injection 1g 0.5% drops, 1% ointment (see chapter 11: Eye) | MICRO Approval Required For treatment of serious / life threatening infections & resistant cases; also used to treat Haemophilus influenza |
| DAPTOMYCIN | Injection 350mg, 500mg | RESTRICTED MICROBIOLOGY CONSULTANT APPROVAL REQUIRED Treatment of resistant gram+ve bacteria (where 1st/2nd line antibiotics have failed/or not appropriate) |
| FIDAXOMICIN | Tablets 200mg | MICRO Approval required RESTRICTED 1st line treatment for toxin positive haematology patients and severe/recurrent cases (on microbiology advice)CDI change of treatment Jan 2017 *NICE Summary – Clostridium difficile infection [ESNM1] Fidaxomicin SMC approval* Updated Microbiology Guidelines to follow |
| FOSFOMYCIN | 3g Oral Sachet | [ESBL UTI] Unlicensed Use DOSE FEMALES = 1x 3g sachet stat DOSE MALES = 2x 3g sachet (one stat & one in 3 days – provide full course on discharge) Tx for ESBL UTI does not require MICRO approval. Approval required for all other indications. |
| 40mg/ml Powder for Solution | RESTRICTED USE MICRO approval 1. Multi-resistant organisms 2. ESBL 3. Carbapenum resistant organisms eMC Compendium | |
| SODIUM FUSIDATE (fusidic acid) | Tablets 250mg Suspension 250mg in 5ml Injection 500mg | |
| LINEZOLID | Tablets 600mg Injection 600mg in 300ml | RESTRICTED MICROBIOLOGY CONSULTANT Approval Required For treatment of serious gram +ve infections with no suitable alternative |
| TRIMETHOPRIM | Tablets 100mg Suspension 50mg in 5ml 100 mg in 5ml Injection | Note: interaction with methotrexate – do not co-prescribe Also used in lower UTI & prostatitis |
| RIFAMYCINS | NOTES | |
| RIFABUTIN | Capsules 150mg | RESTRICTED USE Requires MICRO or RESP approval |
| RIFAXIMIN | Tablets 550mg | GASTRO / LIVER Consultant Restricted For treatment of hepatic encephalopathy APC traffic light status: AMBER APC Statement – Rifaximin for prevention of hepatic encephalopathy NICE Guidance Rifaximin for preventing episodes of overt hepatic encephalopathy [TA 337] |
| 2.2 Leprosy | ||
| ANTIMYCOBACTERIALS | NOTES | |
| DAPSONE | Tablets 50mg | |
| 2.5 Tuberculosis | ||
| ANTIMYCOBACTERIALS – rifamycins | NOTES | |
| VORACTIV (ethambutol + Isoniazid + Pyrazinamide + Rifampicin) | Tablets [Ethambutol 275 mg, Isoniazid 75 mg, Pyrazinamide 400 mg, Rifampicin 150 mg] | RESTRICTED USE Requires MICRO or RESP approval |
| RIFAMPICIN | Capsules 150mg, 300mg Syrup 100mg in 5ml Injection 600mg | RESTRICTED USE Requires MICRO or RESP approval |
| RIFINAH (Rifampicin + Isoniazid) | 150 Tablets [Rifampicin 150mg + Isoniazid 100mg ] 300 Tablets [Rifampicin 300mg + Isoniazid 150mg] | RESTRICTED USE Requires MICRO or RESP approval |
| RIFATER (Rifampicin + Isoniazid + Pyrazinamide) | Tablets Rifampicin 120mg + Isoniazid 50mg + Pyrazinamide 300mg] | RESTRICTED USE Requires MICRO or RESP approval |
| ANTIMYCOBACTERIALS – other | NOTES | |
| CAPREOMYCIN | 1g Injection (1MU) | RESTRICTED USE Requires MICRO or RESP approval |
| CYCLOSERINE | 250mg Capsules | RESTRICTED USE Requires MICRO or RESP approval |
| ETHAMBUTOL | Tablets 100mg | RESTRICTED USE Requires MICRO or RESP approval.Use Voractiv if unavailable if shortage of Ethambutol. |
| ISONIAZID | Tablets 100mg Injection 25mg/ml | RESTRICTED USE Requires MICRO or RESP approval |
| PYRAZINAMIDE | Tablets 500mg | RESTRICTED USE Requires MICRO or RESP approval |
| 2.1 Urinary tract infections | ||
| NITROFURANTOIN | Capsules 50mg | |
| 3 Fungal Infection | ||
| ANTIFUNGALS – echinocandin antifungals | NOTES | |
| CASPONFUNGIN | 50mg, 70mg vials | RESCRICTED to prescribing by Microbiology, ICU and Haematology clinicians and other clinical departments on the advice of Microbiology.
|
| ANTIFUNGALS – polyene antifungals | NOTES | |
| AMPHOTERICIN B (LIPOSOMAL) (AMBISOME) | Injection 50mg | RESTRICTED May be prescribed when recommended on Microguide (Haematology/oncology). MICRO Approval Required for all other indications. |
| NYSTATIN | Suspension 100,000 units/ml | oral thrush – see chapter 12 |
| ANTIFUNGALS – triazole antifungals | NOTES | |
| FLUCONAZOLE | Capsules 50mg Suspension 50mg in 5ml Infusion 2mg/ml | |
| ITRACONAZOLE | Capsules 100mg Liquid 10mg/ml | |
| POSACONAZOLE | Tablets 100mg Suspension 40mg/ml | RESTRICTED May be prescribed when recommended on Microguide (haematology/oncology) or where susceptibility testing results preclude other choices. MICRO Approval Required for all other indications.
SASH Guideline for the management of neutropenic sepsis, antifungal treatment, and prophylaxis. HIGH COST DRUG (PBR excluded) MHRA Drug Safety Update – posaconazole tablets and suspension are not directly interchangeable |
| VORICONAZOLE | Tablets 50mg, 200mg Suspension 40mg/5ml Infusion 200mg | RESTRICTED May be prescribed when recommended on Microguide or where susceptibility testing results preclude other choices. MICRO Approval Required for all other indications except if haemotology. Microguide Antifungal guideline HIGH COST DRUG (PBR excluded) |
| FLUCYTOSINE | Tablets 500mg (unlicensed) Injection 2.5g in 250ml | MICRO APPROVAL REQUIRED Use for the treatment of Cryptococcal meningitis on advice of GUM Physician is exempt from MICRO approval. |
| GRISEOFULVIN | Tablets 500mg | |
| 4 Helminth Infection | ||
| ANTHELMINTICS | NOTES | |
| SASH Antimicrobial Guidelines | Antimicrobial prescribing – Guidelines and Policy | |
| ALBENDAZOLE | 200mg and 400mg tablets | Microbiology consultant approval required. (Unlicensed product) |
| IVERMECTIN | 3mg tablets | Microbiology approval required. (Unlicensed product) |
| MEBENDAZOLE | 100 mg Tablets 100 mg in 5ml Suspension | RESERVED for treatment of threadworm, roundworm (ascaris) & hookworm |
| PRAZIQUANTEL | 150mg, 500mg and 600mg tablets. | Schistosome infections. Microbiology approval required. (Unlicensed product) |
| 5 Protozoal Infection | ||
| 5.2 Malaria | ||
| ANTIPROTAZOALS – antimalarials | NOTES | |
| ARTEMETHER +LUMEFANTRINE | 20mg / 120mg | First-line treatment of Uncomplicated Falciparum malaria |
| ARTESUNATE | 60mg injection | First-line treatment of Complicated Falciparum malaria Unlicensed product ‘named patient’ |
| CHLOROQUINE SULPHATE | 200mg in 5mL Injection | Treatment of benign malaria (vivax) |
| MEFLOQUINE | 250 mg Tablets | Treatment of malaria (falciparum & vivax) |
| PRIMAQUINE | 7.5mg Tablets | RESTRICTED USE Adjunt treatment of benign malaria (plasmodium vivax & plasmodium ovale) |
| PROGUANIL | 100 mg Tablets | Chemoprophylaxis of malaria |
| QUININE SULPHATE | 200mg & 300 mg Tablets | Treatment of malaria falciparum |
| QUININE DIHYDROCHLORIDE | 300 mg /mL Injection | RESTRICTED USE Treatment malaria falciparum |
| 5.2 Toxoplasmosis | ||
| ANTIPROTAZOALS | NOTES | |
| PYRIMETHAMINE | 25 mg Tablets | RESTRICTED USE. Treatment of toxoplasmosis |
| 6. Viral Infection | ||
| 6.2a Chronic hepatitis B | ||
| ANTIVIRALS – nucleoside analogues | NOTES | |
| ENTECAVIR | Tablets 500micrograms, 1mg | NICE TA 153 NHS England Funded |
| TENOFOVIR DISOPROXIL | 245 mg Tablets | VIREAD |
| ADEFOVIR DIPIVOXIL | 10mg Tablets | HIGH COST DRUG Payment by Results Excluded Restricted to Consultant prescribing only Download Authorisation Form |
| PEGINTERFERON ALFA | (Pegasys) 180 microgramme / 0.5ml pre-filled syringe | HIGH COST DRUG Payment by Results Excluded Restricted to Consultant prescribing only Download Authorisation Form |
| 6.2b Chronic hepatitis C | ||
| ANTIVIRALS – nucleoside analogues | NOTES | |
| RIBAVIRIN | 200 mg Tablets | HIGH COST DRUG Payment by Results Excluded Restricted to Consultant prescribing only Download Authorisation Form |
| 6g for Inhalation (Virazole) (reconstitute 6g with 300ml water for injections) | Restricted to Paediatric Consultant prescribing only | |
| 6.3 Herpesvirus infections | ||
| HERPES SIMPLEX AND VARICELLA-ZOSTER | NOTES | |
| ACICLOVIR | Tablets 200mg, 400mg, 800mg Suspension 200mg in 5ml Injection 250mg, 500mg | |
| FAMCICLOVIR | Tablets 125mg, 250mg | |
| VALACICLOVIR | Tablets 500mg | |
| 6.3a Cytomegalovirus | ||
| ANTIVIRALS – Nucleoside analogues | NOTES | |
| GANCICLOVIR | 500 mg Intravenous Infusion | RESTRICTED USE 1) GUM : Patients with CMV infection under care of GUM physician 2) Patients under HAEM & ONCOLOY 3) All other use under MICRO advice |
| ANTIVIRALS – Other | NOTES | |
| FOSCARNET | 24mg/ml Intravenous Infusion | |
| 6.4 HIV Infection | ||
| NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | NOTES | |
| EFAVIRENZ | 600 mg Tablets | |
| NEVIRAPINE NEVIRAPINE | 200 mg Tablets 50 mg in 5ml Suspension | |
| NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | NOTES | |
| All Nuceloside Reverse Transcriptase Inhibitors are only prescribable for patients with HIV under the care of GUM Physicians | ||
| ABACAVIR | ZIAGEN 300 mg Tablets | |
| ABACAVIR + LAMIVUDINE + ZIDOVUDINE | TRIZIVIR 300mg / 150mg / 300mg Tablets | |
| DIDANOSINE (ddI) | VIDEX-EC 125 mg, 200mg, 250mg, 400mg Gastro-Resistant Capsules | |
| TENOFOVIR + EMTRICITABINE + EFAVIRENZ | ATRIPLA Tablets 600mg / 200mg / 245mg | |
| EMTRICITABINE | EMTRIVA 200mg Capsules EMTRIVA 10mg/ml Oral Solution | |
| EMTRICITABINE + TENOFOVIR | TRUVADA 200mg / 245mg Tablets | |
| LAMIVUDINE (3TC) | EPIVIR 150 mg, 300mg Tablets | |
| STAVUDINE (d4T) | ZERIT 15 mg, 20mg, 40mg Capsules | |
| ZIDOVUDINE (AZT) | RETROVIR 100mg, 250mg Capsules RETROVIR 50 mg in 5mL Syrup | |
| ZIDOVIDINE + LAMIVUDINE | COMBIVIR 300mg + 150mg Tablets | |
| PROTEASE INHIBITORS | NOTES | |
| All Protease Inhibitors are only prescribable for patients with HIV under the care of GUM Physicians | ||
| ATAZANIVIR | REYETAZ100mg, 150mg, 200mg, 300mg Capsules | |
| DARUNAVIR | PERZISTA 300 mg Tablets | |
| LOPINAVIR + RITONAVIR | KALETRA 200mg/50mg tablet | |
| RITONAVIR | 100 mg Capsules 400 mg in 5mL Oral Solution | NORVIR |
| SAQUINAVIR | 200 mg Capsules | |
| 6.5 Influenza | ||
| INFLUENZA – Neuraminidase inhibitors | NOTES | |
| Public Health England Guidance (2016) | PHE guidance – antiviral agents for treatment and prophylaxis of influenza | |
| OSELTAMIVIR | [TAMIFLU] Capsules 75mg | Amantadine, oseltamivir and zanamivir for the treatment of influenza [TA168] Amantadine, oseltamivir (review) and zanamivir for the prophylaxis of influenza [TA158] |
| ZANAMIVIR | Inhalation Disks 5mg/blister (Relenza) Aqueous solution for injection or nebulisation | All requests through Chief Pharmacist Amantadine, oseltamivir and zanamivir for the treatment of influenza [TA168] Amantadine, oseltamivir (review) and zanamivir for the prophylaxis of influenza [TA158] PHE Influenza: treatment and prophylaxis using anti-viral agents |
| BNF CODE – 5.3.5 | ||
| RESPIRATORY SYNCYTIAL VIRUS | NOTES | |
| Date of revision | Sections Reviewed | Reviewer |
| 8/2/17 | Tania Beadling | |
1. Gastro-Intestinal System | 2. Cardiovascular System | 3. Respiratory System | 4. Central Nervous System | 5. Antimicrobials | 6. Endocrine System | 7. Obstetrics, Gynaecology & Urology | 8. Malignant Disease & Immunosuppression | 9. Nutrition & Blood | 10. Musculoskelatal & Joint Diseases | 11. Opthalmology | 12. Ear, Nose & Oropharynx | 13. Dermatology | 14. Immunology & Vaccines | 15. Anaesthetics | GP Centre Home